secwatch.observer — SEC 8-K summary
======================================

Issuer:     SERA PROGNOSTICS, INC. (SERA)
CIK:        0001534969
Form:       8-K
Filed at:   2024-03-20T23:59:59+00:00
Accession:  0001534969-24-000054
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sera Prognostics reports Q4/FY2023 results; DSMB stops PRIME study early for efficacy
--------------------------------------------------------------------------------

- DSMB recommended stopping PRIME enrollment after co-primary endpoints met significance at interim analysis; preparing manuscript.
- Q4 2023 revenue $41K; full-year revenue $306K; net loss $7.9M (Q4) and $36.2M (FY), improved from prior year.
- Operating expenses down to $8.9M (Q4) from $10.5M; SG&A reduced to $5.0M from $6.9M.
- Cash and securities $79.9M as of Dec 31, 2023.
- Progress on PreTRM sample collection enhancements; launching in certain geographies; building patient-facing products.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534969/000153496924000054/0001534969-24-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534969/000153496924000054/sera-20240320.htm
  HTML page:      https://secwatch.observer/filing/0001534969-24-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer